Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia

被引：0
|
作者：
Sirvent, JLG [1 ]
Socas, MMA [1 ]
Calzadilla, CH [1 ]
Lirola, AML [1 ]
Valls, MRA [1 ]
机构：
[1] Hosp Univ Canarias, Lab Serv, Infect Dis Serv, Tenerife, Spain
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 40卷 / 01期
关键词：
D O I：
10.1097/01.qai.0000174650.33159.22
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：111 / 113
页数：3
相关论文
共 50 条
  • [1] Antiretroviral Drug Resistance in HIV-1-Infected Patients with Low-Level Viremia
    Mackie, Nicola E.
    Phillips, Andrew N.
    Kaye, Steve
    Booth, Clare
    Geretti, Anna-Maria
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (09): : 1303 - 1307
  • [2] Genotypic resistance in HIV-1 - Infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy
    Nettles, RE
    Kieffer, TL
    Simmons, RP
    Cofrancesco, J
    Moore, RD
    Gallant, JE
    Persaud, D
    Siliciano, RF
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1030 - 1037
  • [3] Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia
    Li, Jonathan Z.
    Gallien, Sebastien
    Do, Tri D.
    Martin, Jeffrey N.
    Deeks, Steven
    Kuritzkes, Daniel R.
    Hatano, Hiroyu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5998 - 6000
  • [4] A Concentration Method for HIV Drug Resistance Testing in Low-Level Viremia Samples
    Li, Qun
    Yu, Fengting
    Song, Chuan
    Zhao, Hongxin
    Yan, Liting
    Xiao, Qing
    Lao, Xiaojie
    Yang, Siyuan
    Tang, Yunxia
    Xiao, Jiang
    Zhang, Fujie
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [5] Genotypic resistance in patients with persistently detectable low-level viraemia treated with triple nucleoside antiretroviral therapy
    Amiel, C
    Da Silva, EM
    Schneider, V
    Thevenet, S
    Clavel, F
    Rozenbaum, W
    ANTIVIRAL THERAPY, 2005, 10 : S21 - S21
  • [6] Genotypic resistance in patients with persistently detectable low-level viraemia treated with triple nucleoside antiretroviral therapy
    Amiel, C
    Da Silva, EM
    Schneider, V
    Thevenet, S
    Clavel, F
    Rozenbaum, W
    ANTIVIRAL THERAPY, 2005, 10 (04) : S21 - S21
  • [7] Efficacy of genotypic drug resistance testing in patients with low-level plasma HIV-1 viremia
    Parczewski, Milosz
    Leszczyszyn-Pynka, Magdalena
    Witak-Jedra, Magdalena
    Maciejewska, Katarzyna
    Urbanska, Anna
    HIV & AIDS REVIEW, 2015, 14 (03): : 80 - 83
  • [8] A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples
    Gupta, Shivani
    Taylor, Tracy
    Patterson, Aileen
    Liang, Binhua
    Bullard, Jared
    Sandstrom, Paul
    Van Domselaar, Gary
    Ji, Hezhao
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [9] The prevalence of antiretroviral drug resistance in patients with low-level detectable viraemia while on HAART
    Booth, C. L.
    Garcia-Diaz, A.
    Nebbia, G.
    Youle, M.
    Johnson, M.
    Geretti, A. M.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S130 - S130
  • [10] Natural history of patients with low-level HIV viremia on antiretroviral therapy
    Lo Re, V
    Gasink, L
    Kostman, JR
    Leonard, D
    Gross, R
    AIDS PATIENT CARE AND STDS, 2004, 18 (08) : 436 - 442
12345